查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1573045

植物来源药物市场：按类型、来源、治疗应用、配方、最终用户、给药途径- 2025-2030 年全球预测

Botanical Drug Market by Type (Herbal Drugs, Nutraceuticals, Phytomedicines), Source (Algae, Fungi, Plants), Therapeutic Application, Formulation, End User, Route Of Administration - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年植物来源市值为37.5亿美元，预计到2024年将达到40.1亿美元，复合年增长率为6.96%，到2030年预计将达到60.1亿美元。

植物药物被定义为植物来源的复杂混合物，由于其天然来源和治疗潜力而越来越受欢迎。这些药物包括各种形式，如酊剂、茶和精油，特别注重标准化具有药用特性的萃取物。消费者对天然和永续医疗保健选择的日益偏好以及全球监管机构的日益接受推动了对植物药的需求。植物药物主要用于治疗关节炎、心血管疾病和癌症等慢性疾病，这些疾病的传统治疗方法很难或有显着的副作用。最终用途范围包括製药、食品和个人护理行业，受益于人们对传统医学和整体健康日益增长的兴趣。根据市场洞察，关键的成长要素包括研发投资的活性化、有利的法规以及公众对植物来源健康解决方案的认识不断提高。最新的商机是将植物疗法的应用扩展到个人化和整合医学。利用这些机会的研究包括培养策略研究伙伴关係、优化永续采购的供应链以及参与公共卫生教育。然而，它们也有局限性，包括复杂的法律规范、与合成物相比有限的临床资料，以及由于自然变异而保持产品一致性的挑战。此外，供应链中断和严格的专利法可能会阻碍市场成长。最佳创新领域包括改进萃取方法、开发标准化配方以及利用生物技术的进步来提高植物药物的治疗功效和安全性。由于市场分散，中小企业众多，因此有充分的机会透过有针对性的创新和敏捷的业务策略来建立利基领导地位。了解消费者趋势和投资可扩展的基础设施对于驾驭植物医学的复杂格局至关重要，而跟上不断变化的监管格局对于提高竞争力至关重要。

主要市场统计
基准年[2023] 37.5亿美元
预测年份 [2024] 40.1亿美元
预测年份 [2030] 60.1亿美元
复合年增长率（%） 6.96%

市场动态：揭示快速发展的植物来源药物市场的关键市场洞察

植物来源市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 支持植物药发展的政府措施和资金
    • 拓展植物产品通路与电商平台
    • 在植物来源药物生产中采用先进的萃取和配方技术
    • 主要市场参与者对植物来源药物研究和商业化进行了大量投资
  • 市场限制因素
    • 关于植物药功效和安全性的临床试验资料和科学检验有限
    • 智慧财产权挑战和合成药物的竞争阻碍了市场成长
  • 市场机会
    • 慢性病盛行率的增加增加了植物药物替代治疗的采用
    • 透过扩大分销管道（包括电子商务平台）来提高市场覆盖率和可及性
    • 开拓满足个人健康需求和偏好的个人化植物药市场将推动市场成长
  • 市场挑战
    • 支持植物来源药物功效和安全性主张的科学证据和临床试验有限，阻碍了市场成长
    • 供应链中断和原材料短缺影响植物来源製药业的生产一致性

波特五力：驾驭植物来源药物市场的策略工具

波特的五力架构是了解植物来源市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解植物来源医药市场的外部影响

外部宏观环境因素在塑造植物来源市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解植物来源市场的竞争状况

对植物来源药物市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵植物来源药品市场供应商的绩效评估

FPNV定位矩阵是评估植物来源市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了植物来源市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对植物来源市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 支持植物药发展的政府措施和资金
      • 扩大植物来源产品的通路与电子商务平台
      • 在植物来源药物生产中采用先进的萃取和复合技术
      • 主要市场参与者对植物来源药物的研究和商业化进行了大量投资
    • 抑制因素
      • 植物药功效和安全性的临床试验资料和科学检验有限。
      • 智慧财产权挑战和合成药物的竞争阻碍了市场成长
    • 机会
      • 慢性病盛行率上升增加了植物药物替代疗法的采用
      • 扩大分销管道，包括电子商务平台，扩大市场覆盖范围和可及性
      • 根据个人健康需求和偏好开发个人化植物药物将推动市场成长
    • 任务
      • 支持功效和安全性主张的科学证据和临床试验有限，阻碍了市场成长
      • 供应链中断和原材料短缺影响植物来源製药业的生产一致性
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章植物来源药物市场：依类型

  • 草药
    • 多种草药
    • 单一草药
  • 食品补充品
  • 植物药

第七章植物来源药物市场：依来源分类

  • 藻类
  • 真菌
  • 植物
    • 吠
    • 叶子
    • 根
    • 种子

第八章植物来源

  • 癌症
  • 心血管疾病
  • 糖尿病
  • 消化系统疾病
  • 呼吸系统疾病

第九章植物来源药物处方市场

  • 胶囊
  • 摘抄
  • 软膏
  • 粉末
  • 药片

第十章植物来源药物市场：依最终用户分类

  • 诊所
  • 居家护理
  • 医院

第十一章植物来源药物市场：依给药途径

  • 可注射的
  • 口服
  • 话题

第十二章美洲植物来源市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太植物来源市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章欧洲、中东和非洲植物来源药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C04EA

The Botanical Drug Market was valued at USD 3.75 billion in 2023, expected to reach USD 4.01 billion in 2024, and is projected to grow at a CAGR of 6.96%, to USD 6.01 billion by 2030.

Botanical drugs, defined as complex mixtures derived from plant-based sources, have been gaining traction due to their natural origin and therapeutic potential. These drugs encompass various forms, including tinctures, teas, and essential oils, focusing especially on standardizing extracts with medicinal properties. The necessity for botanical drugs stems from the rising consumer preference for natural, sustainable healthcare options coupled with increased acceptance by global regulatory bodies. They are primarily applied in treating chronic diseases, such as arthritis, cardiovascular ailments, and cancer, where conventional treatments may falter or present significant side effects. The scope of end-use includes pharmaceutical, nutraceutical, and personal care industries, benefitting from growing interests in traditional medicine and holistic health. Market insights reveal that key growth factors include heightened R&D investments, favorable regulations, and increased public awareness of plant-based health solutions. Latest opportunities lie in personalizing botanical therapies and expanding applications in integrative medicine practices. Recommendations to capitalize on these opportunities include fostering strategic partnerships for research, optimizing supply chains for sustainable sourcing, and engaging in public health education. However, limitations include complex regulatory frameworks, limited clinical data compared to synthetics, and challenges in maintaining product consistency due to natural variability. Additionally, supply chain disruptions and stringent patent laws can hinder market growth. The best areas for innovation involve improving extraction methods, developing standardized formulations, and leveraging biotechnological advancements to enhance therapeutic efficacy and safety profiles of botanical drugs. As the market is characterized by fragmentation with numerous small to mid-sized firms, opportunities abound for establishing niche leadership through targeted innovations and agile business strategies. Understanding consumer trends and investing in a scalable infrastructure is crucial for navigating the complex landscape of botanical drugs, while staying abreast of evolving regulatory standards can provide a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 3.75 billion
Estimated Year [2024] USD 4.01 billion
Forecast Year [2030] USD 6.01 billion
CAGR (%) 6.96%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Botanical Drug Market

The Botanical Drug Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Government initiatives and funding supporting the development of botanical drugs
    • Expansion of distribution channels and e-commerce platforms for botanical products
    • Adoption of advanced extraction and formulation technologies in botanical drug manufacturing
    • Significant investments by key market players in botanical drug research and commercialization
  • Market Restraints
    • Limited clinical trial data and scientific validation on the efficacy and safety of botanical drugs
    • Intellectual property challenges and competition with synthetic drugs impede market growth
  • Market Opportunities
    • Rising prevalence of chronic diseases increasing the adoption of botanical drugs for alternative treatment
    • Expansion of distribution channels including e-commerce platforms boosting market reach and accessibility
    • Development of personalized botanical medicine catering to individual health needs and preferences driving market growth
  • Market Challenges
    • Limited scientific evidence and clinical trials to support botanical drug efficacy and safety claims hamper market growth
    • Supply chain disruptions and raw material scarcity affect production consistency in the botanical drug industry

Porter's Five Forces: A Strategic Tool for Navigating the Botanical Drug Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Botanical Drug Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Botanical Drug Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Botanical Drug Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Botanical Drug Market

A detailed market share analysis in the Botanical Drug Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Botanical Drug Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Botanical Drug Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Botanical Drug Market

A strategic analysis of the Botanical Drug Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Botanical Drug Market, highlighting leading vendors and their innovative profiles. These include Aphios Corporation, Botanix Pharmaceuticals Ltd, CanniMed Therapeutics Inc., Cardiol Therapeutics Inc., CV Sciences, Inc., Ecofibre Limited, EcoGen Laboratories, Emerald Health Pharmaceuticals, GB Sciences, Inc., GW Pharmaceuticals plc, HempMeds, InMed Pharmaceuticals Inc., Jazz Pharmaceuticals plc, Lexaria Bioscience Corp., MediPharm Labs Corp., PhytoTech Therapeutics Ltd., Tetra Bio-Pharma Inc., Tikun Olam Ltd., Veritas Pharma Inc., and Zynerba Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Botanical Drug Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Herbal Drugs, Nutraceuticals, and Phytomedicines. The Herbal Drugs is further studied across Multiple Herb Drugs and Single Herb Drugs.
  • Based on Source, market is studied across Algae, Fungi, and Plants. The Plants is further studied across Barks, Leaves, Roots, and Seeds.
  • Based on Therapeutic Application, market is studied across Cancer, Cardiovascular Diseases, Diabetes, Digestive Disorders, and Respiratory Disorders.
  • Based on Formulation, market is studied across Capsules, Extracts, Ointments, Powders, and Tablets.
  • Based on End User, market is studied across Clinics, Homecare, and Hospitals.
  • Based on Route Of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government initiatives and funding supporting the development of botanical drugs
      • 5.1.1.2. Expansion of distribution channels and e-commerce platforms for botanical products
      • 5.1.1.3. Adoption of advanced extraction and formulation technologies in botanical drug manufacturing
      • 5.1.1.4. Significant investments by key market players in botanical drug research and commercialization
    • 5.1.2. Restraints
      • 5.1.2.1. Limited clinical trial data and scientific validation on the efficacy and safety of botanical drugs
      • 5.1.2.2. Intellectual property challenges and competition with synthetic drugs impede market growth
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising prevalence of chronic diseases increasing the adoption of botanical drugs for alternative treatment
      • 5.1.3.2. Expansion of distribution channels including e-commerce platforms boosting market reach and accessibility
      • 5.1.3.3. Development of personalized botanical medicine catering to individual health needs and preferences driving market growth
    • 5.1.4. Challenges
      • 5.1.4.1. Limited scientific evidence and clinical trials to support botanical drug efficacy and safety claims hamper market growth
      • 5.1.4.2. Supply chain disruptions and raw material scarcity affect production consistency in the botanical drug industry
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Botanical Drug Market, by Type

  • 6.1. Introduction
  • 6.2. Herbal Drugs
    • 6.2.1. Multiple Herb Drugs
    • 6.2.2. Single Herb Drugs
  • 6.3. Nutraceuticals
  • 6.4. Phytomedicines

7. Botanical Drug Market, by Source

  • 7.1. Introduction
  • 7.2. Algae
  • 7.3. Fungi
  • 7.4. Plants
    • 7.4.1. Barks
    • 7.4.2. Leaves
    • 7.4.3. Roots
    • 7.4.4. Seeds

8. Botanical Drug Market, by Therapeutic Application

  • 8.1. Introduction
  • 8.2. Cancer
  • 8.3. Cardiovascular Diseases
  • 8.4. Diabetes
  • 8.5. Digestive Disorders
  • 8.6. Respiratory Disorders

9. Botanical Drug Market, by Formulation

  • 9.1. Introduction
  • 9.2. Capsules
  • 9.3. Extracts
  • 9.4. Ointments
  • 9.5. Powders
  • 9.6. Tablets

10. Botanical Drug Market, by End User

  • 10.1. Introduction
  • 10.2. Clinics
  • 10.3. Homecare
  • 10.4. Hospitals

11. Botanical Drug Market, by Route Of Administration

  • 11.1. Introduction
  • 11.2. Injectable
  • 11.3. Oral
  • 11.4. Topical

12. Americas Botanical Drug Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Botanical Drug Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Botanical Drug Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aphios Corporation
  • 2. Botanix Pharmaceuticals Ltd
  • 3. CanniMed Therapeutics Inc.
  • 4. Cardiol Therapeutics Inc.
  • 5. CV Sciences, Inc.
  • 6. Ecofibre Limited
  • 7. EcoGen Laboratories
  • 8. Emerald Health Pharmaceuticals
  • 9. GB Sciences, Inc.
  • 10. GW Pharmaceuticals plc
  • 11. HempMeds
  • 12. InMed Pharmaceuticals Inc.
  • 13. Jazz Pharmaceuticals plc
  • 14. Lexaria Bioscience Corp.
  • 15. MediPharm Labs Corp.
  • 16. PhytoTech Therapeutics Ltd.
  • 17. Tetra Bio-Pharma Inc.
  • 18. Tikun Olam Ltd.
  • 19. Veritas Pharma Inc.
  • 20. Zynerba Pharmaceuticals, Inc.

LIST OF FIGURES

  • FIGURE 1. BOTANICAL DRUG MARKET RESEARCH PROCESS
  • FIGURE 2. BOTANICAL DRUG MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BOTANICAL DRUG MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BOTANICAL DRUG MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BOTANICAL DRUG MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BOTANICAL DRUG MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. BOTANICAL DRUG MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. BOTANICAL DRUG MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BOTANICAL DRUG MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BOTANICAL DRUG MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BOTANICAL DRUG MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BOTANICAL DRUG MARKET DYNAMICS
  • TABLE 7. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BOTANICAL DRUG MARKET SIZE, BY MULTIPLE HERB DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SINGLE HERB DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BOTANICAL DRUG MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BOTANICAL DRUG MARKET SIZE, BY PHYTOMEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ALGAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FUNGI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BOTANICAL DRUG MARKET SIZE, BY PLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BOTANICAL DRUG MARKET SIZE, BY BARKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BOTANICAL DRUG MARKET SIZE, BY LEAVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROOTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SEEDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BOTANICAL DRUG MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BOTANICAL DRUG MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BOTANICAL DRUG MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BOTANICAL DRUG MARKET SIZE, BY EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BOTANICAL DRUG MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BOTANICAL DRUG MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BOTANICAL DRUG MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. POLAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. QATAR BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. RUSSIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 318. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 326. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 332. SPAIN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 333. SPAIN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 334. SPAIN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 340. SWEDEN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 341. SWEDEN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 342. SWEDEN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 346. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 348. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 350. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 354. TURKEY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 355. TURKEY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 356. TURKEY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 357. TURKEY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 358. TURKEY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 362. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 363. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 364. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 365. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 366. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 367. UNITED KINGDOM BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 368. UNITED KINGDOM BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 369. UNITED KINGDOM BOTANICAL DRUG MARKET SIZE, BY SOURCE, 201